Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 283.50
-2.00 (-0.70%)
At close: Dec 23, 2025
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 74.55 billion as of December 23, 2025. Its market cap has increased by 1.49% in one year.
Market Cap
74.55B
Enterprise Value
81.30B
Revenue
18.66B
Ranking
n/a
PE Ratio
15.71
Stock Price
283.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 74.55B, an increase of 711.49%. That is a compound annual growth rate of 20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 74.55B | 4.24% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.02B |
| PharmaEssentia | 183.81B |
| Heron Neutron Medical | 85.13B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 30.91B |
| Center Laboratories | 28.37B |
| Oneness Biotech | 27.84B |